Browse by UCL Departments and Centres
Group by: Author | Type
Number of items: 17.
A
Amador, S;
Rapaport, P;
Lang, I;
Sommerlad, A;
Mukadam, N;
Stringer, A;
Hart, N;
... Livingston, G; + view all
(2021)
Implementation of START (STrAtegies for RelaTives) for dementia carers in the third sector: Widening access to evidence-based interventions.
PLoS ONE
, 16
(6)
, Article e0250410. 10.1371/journal.pone.0250410.
![]() |
![]() |
B
Brown, S;
Livingston, G;
Mukadam, N;
(2021)
A national memory clinic survey to assess provision for people from diverse ethnic backgrounds in England and Wales.
International Journal of Environmental Research and Public Health
, 18
(4)
, Article 1456. 10.3390/ijerph18041456.
![]() |
![]() |
C
Cenko, B;
Ozgo, E;
Rapaport, P;
Mukadam, N;
(2021)
Prevalence of Dementia in Older Adults in Central and Eastern Europe: A Systematic Review and Meta-Analysis.
Psychiatry International
, 2
(2)
pp. 191-210.
10.3390/psychiatryint2020015.
![]() |
![]() |
F
Franzen, S;
European Consortium on Cross-Cultural Neuropsychology (ECCroN);
Bekkhus-Wetterberg, P;
van den Berg, E;
Calia, C;
Canevelli, M;
Daugherty, JC;
... Watermeyer, TJ; + view all
(2021)
Cross-cultural neuropsychological assessment in Europe: Position statement of the European Consortium on Cross-Cultural Neuropsychology (ECCroN).
The Clinical Neuropsychologist
10.1080/13854046.2021.1981456.
(In press).
![]() |
![]() |
J
James, T;
Mukadam, N;
Sommerlad, A;
Guerra Ceballos, S;
Livingston, G;
(2021)
Culturally tailored therapeutic interventions for people affected by dementia: a systematic review and new conceptual model.
The Lancet Healthy Longevity
, 2
(3)
e171-e179.
10.1016/S2666-7568(21)00001-5.
![]() |
![]() |
L
Liu, KY;
Howard, R;
(2021)
Can we learn lessons from the FDA's approval of aducanumab?
Nature Reviews Neurology
, 17
pp. 715-722.
10.1038/s41582-021-00557-x.
![]() |
Liu, KY;
Howard, R;
(2021)
Pimavanserin and dementia-related psychosis: can HARMONY prevail?
The Lancet Neurology
, 20
(10)
pp. 783-784.
10.1016/s1474-4422(21)00257-x.
![]() |
Liu, KY;
Howard, R;
Banerjee, S;
Comas‐Herrera, A;
Goddard, J;
Knapp, M;
Livingston, G;
... Burns, A; + view all
(2021)
Dementia wellbeing and COVID‐19: Review and expert consensus on current research and knowledge gaps.
International Journal of Geriatric Psychiatry
, 36
(11)
pp. 1597-1639.
10.1002/gps.5567.
![]() |
![]() |
Liu, KY;
Mukadam, N;
(2021)
Frailty and dementia: what can the body tell us about the brain?
International Psychogeriatrics
, 33
(10)
pp. 1001-1003.
10.1017/S1041610220004160.
![]() |
Liu, KY;
Schneider, LS;
Howard, R;
(2021)
The need to show minimum clinically important differences in Alzheimer's disease trials.
The Lancet Psychiatry
, 8
(11)
pp. 1013-1016.
10.1016/s2215-0366(21)00197-8.
![]() |
Liu, KY;
Acosta-Cabronero, J;
Hong, YT;
Yi, Y-J;
Hämmerer, D;
Howard, R;
(2021)
FDG-PET assessment of the locus coeruleus in Alzheimer’s disease.
Neuroimage: Reports
, 1
(1)
, Article 100002. 10.1016/j.ynirp.2020.100002.
![]() |
![]() |
Liu, KY;
Borissova, A;
Mahmood, J;
Elliott, T;
Knowles, M;
Bentham, P;
Reeves, S;
(2021)
Pharmacological treatment trials of agitation in Alzheimer's disease: A systematic review of ClinicalTrials.gov registered trials.
Alzheimer's & Dementia: Translational Research & Clinical Interventions
, 7
(1)
, Article e12157. 10.1002/trc2.12157.
![]() |
![]() |
M
Ma'u, E;
Cullum, S;
Cheung, G;
Livingston, PG;
Mukadam, N;
(2021)
Differences in the potential for dementia prevention between major ethnic groups within one country: A cross sectional analysis of population attributable fraction of potentially modifiable risk factors in New Zealand.
The Lancet Regional Health - Western Pacific
, 13
, Article 100191. 10.1016/j.lanwpc.2021.100191.
![]() |
![]() |
Mukadam, N;
Sommerlad, A;
Wright, J;
Smith, A;
Szczap, A;
Solomou, S;
Bhome, R;
... Carlos Bazo-Alvarez, J; + view all
(2021)
Acute mental health presentations before and during the COVID-19 pandemic.
BJPsych Open
, 7
(4)
, Article e134. 10.1192/bjo.2021.970.
![]() |
![]() |
R
Reeves, S;
Howard, R;
Bramon, E;
Liu, K;
Bertrand, J;
Uchida, H;
yoshida, K;
... ozer, M; + view all
(2021)
Towards safer risperidone prescribing in Alzheimer's disease.
British Journal of Psychiatry
, 218
(5)
pp. 268-275.
10.1192/bjp.2020.225.
![]() |
Y
Yu, R-C;
Mukadam, N;
Kapur, N;
Stott, J;
Hu, C-J;
Hong, C-T;
Yang, C-C;
... Livingston, G; + view all
(2021)
Validation of the Taiwanese Version of ACE-III (T-ACE-III) to Detect Dementia in a Memory Clinic.
Archives of Clinical Neuropsychology
, Article acab089. 10.1093/arclin/acab089.
![]() |
![]() |
Z
Zabihi, S;
Jones, R;
Moran, P;
King, M;
Osborn, D;
Pitman, A;
(2021)
The Association Between Personality Disorder Traits and Suicidality Following Sudden Bereavement: A National Cross-Sectional Survey.
Journal of Personality Disorders
, 35
(6)
pp. 917-935.
10.1521/pedi_2021_35_520.
![]() |